1. Home
  2. PODD vs SWKS Comparison

PODD vs SWKS Comparison

Compare PODD & SWKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • SWKS
  • Stock Information
  • Founded
  • PODD 2000
  • SWKS 1962
  • Country
  • PODD United States
  • SWKS United States
  • Employees
  • PODD N/A
  • SWKS N/A
  • Industry
  • PODD Medical/Dental Instruments
  • SWKS Semiconductors
  • Sector
  • PODD Health Care
  • SWKS Technology
  • Exchange
  • PODD Nasdaq
  • SWKS Nasdaq
  • Market Cap
  • PODD 16.5B
  • SWKS 14.8B
  • IPO Year
  • PODD 2007
  • SWKS 1968
  • Fundamental
  • Price
  • PODD $275.81
  • SWKS $93.64
  • Analyst Decision
  • PODD Buy
  • SWKS Hold
  • Analyst Count
  • PODD 16
  • SWKS 21
  • Target Price
  • PODD $271.19
  • SWKS $102.59
  • AVG Volume (30 Days)
  • PODD 533.0K
  • SWKS 2.4M
  • Earning Date
  • PODD 02-20-2025
  • SWKS 01-28-2025
  • Dividend Yield
  • PODD N/A
  • SWKS 2.95%
  • EPS Growth
  • PODD 235.68
  • SWKS N/A
  • EPS
  • PODD 5.74
  • SWKS 3.69
  • Revenue
  • PODD $1,983,900,000.00
  • SWKS $4,178,000,000.00
  • Revenue This Year
  • PODD $23.56
  • SWKS N/A
  • Revenue Next Year
  • PODD $18.07
  • SWKS $8.34
  • P/E Ratio
  • PODD $48.09
  • SWKS $25.38
  • Revenue Growth
  • PODD 27.42
  • SWKS N/A
  • 52 Week Low
  • PODD $160.19
  • SWKS $82.13
  • 52 Week High
  • PODD $279.77
  • SWKS $120.86
  • Technical
  • Relative Strength Index (RSI)
  • PODD 61.05
  • SWKS 62.01
  • Support Level
  • PODD $260.84
  • SWKS $90.94
  • Resistance Level
  • PODD $274.45
  • SWKS $93.52
  • Average True Range (ATR)
  • PODD 7.44
  • SWKS 2.04
  • MACD
  • PODD 0.65
  • SWKS 0.27
  • Stochastic Oscillator
  • PODD 88.34
  • SWKS 88.54

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

About SWKS Skyworks Solutions Inc.

Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.

Share on Social Networks: